Healthcare technology company mLHealth360 has appointed Prashant Naidu as Chief Business Officer – India and Emerging Markets, as the company looks to expand its commercial footprint.
In his new role, Naidu will be responsible for building and scaling business across mlHealth360’s product and solution portfolio, focusing on both the public sector and enterprise commercial markets. He will also lead the development and execution of the company’s go-to-market (GTM) strategy for India and other emerging markets, with a focus on creating sustainable commercial growth.
Naidu brings 32 years of experience across healthcare, MedTech and technology. He has held leadership and senior management positions spanning business strategy and growth, sales and business development, strategic key account management, digital transformation and SaaS.
Over the course of his career, he has worked with multiple organisations including Microsoft, Philips Healthcare, GE Healthcare, Siemens, Apollo BSR Hospitals, Qure.ai, Medikabazaar and MyHealthcare Technologies.
Commenting on the appointment, Naidu said, “I have spent more than three decades working across healthcare and technology, and one thing that has remained constant is the need to ensure that technology solves a real problem for the healthcare ecosystem.”
He added that he looked forward to helping mLHealth360 identify opportunities, develop partnerships and scale the company’s business across India and emerging markets, noting that the company is well positioned to “play a much larger role in the next phase of AI-led healthcare.”
The company said Naidu’s extensive experience across healthcare and technology gives him a strong perspective on the market, from customer needs and adoption challenges to the opportunities created by digital transformation and AI.
“As we enter the next phase of our growth, his understanding of public-sector and enterprise healthcare will be particularly valuable. We see this appointment as an important step towards scaling mLHealth360’s business across markets in the coming years,” it said.
AI-enabled solutions can support earlier detection of diseases, help identify asymptomatic cases, assist clinicians in decision-making and improve operational workflows.
mLHealth360 said its portfolio of healthcare AI solutions is aimed at contributing to this evolving healthcare landscape while expanding its commercial footprint across India and emerging markets.
